Literature DB >> 21856937

Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes.

Paul A Ramsland1, William Farrugia, Tessa M Bradford, Caroline Tan Sardjono, Sandra Esparon, Halina M Trist, Maree S Powell, Peck Szee Tan, Angela C Cendron, Bruce D Wines, Andrew M Scott, P Mark Hogarth.   

Abstract

The interaction of Abs with their specific FcRs is of primary importance in host immune effector systems involved in infection and inflammation, and are the target for immune evasion by pathogens. FcγRIIa is a unique and the most widespread activating FcR in humans that through avid binding of immune complexes potently triggers inflammation. Polymorphisms of FcγRIIa (high responder/low responder [HR/LR]) are linked to susceptibility to infections, autoimmune diseases, and the efficacy of therapeutic Abs. In this article, we define the three-dimensional structure of the complex between the HR (arginine, R134) allele of FcγRIIa (FcγRIIa-HR) and the Fc region of a humanized IgG1 Ab, hu3S193. The structure suggests how the HR/LR polymorphism may influence FcγRIIa interactions with different IgG subclasses and glycoforms. In addition, mutagenesis defined the basis of the epitopes detected by FcR blocking mAbs specific for FcγRIIa (IV.3), FcγRIIb (X63-21), and a pan FcγRII Ab (8.7). The epitopes detected by these Abs are distinct, but all overlap with residues defined by crystallography to contact IgG. Finally, crystal structures of LR (histidine, H134) allele of FcγRIIa and FcγRIIa-HR reveal two distinct receptor dimers that may represent quaternary states on the cell surface. A model is presented whereby a dimer of FcγRIIa-HR binds Ag-Ab complexes in an arrangement that possibly occurs on the cell membrane as part of a larger signaling assembly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856937      PMCID: PMC3282893          DOI: 10.4049/jimmunol.1101467

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  The structure of a human type III Fcgamma receptor in complex with Fc.

Authors:  S Radaev; S Motyka; W H Fridman; C Sautes-Fridman; P D Sun
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

2.  Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89.

Authors:  R J Pleass; T Areschoug; G Lindahl; J M Woof
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

3.  Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.

Authors:  P Sondermann; J Kaiser; U Jacob
Journal:  J Mol Biol       Date:  2001-06-08       Impact factor: 5.469

4.  High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

Authors:  R L Shields; A K Namenuk; K Hong; Y G Meng; J Rae; J Briggs; D Xie; J Lai; A Stadlen; B Li; J A Fox; L G Presta
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

Review 5.  Molecular versatility of antibodies.

Authors:  Henry Metzger
Journal:  Immunol Rev       Date:  2002-07       Impact factor: 12.988

6.  Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity.

Authors:  Robert L Shields; Jadine Lai; Rodney Keck; Lori Y O'Connell; Kyu Hong; Y Gloria Meng; Stefanie H A Weikert; Leonard G Presta
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

7.  Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.

Authors:  H M Dijstelbloem; M Bijl; R Fijnheer; R H Scheepers; W W Oost; M D Jansen; W J Sluiter; P C Limburg; R H Derksen; J G van de Winkel; C G Kallenberg
Journal:  Arthritis Rheum       Date:  2000-12

8.  Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha.

Authors:  S C Garman; B A Wurzburg; S S Tarchevskaya; J P Kinet; T S Jardetzky
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

Review 9.  Fcgamma receptors in autoimmune diseases.

Authors:  G Fossati; R C Bucknall; S W Edwards
Journal:  Eur J Clin Invest       Date:  2001-09       Impact factor: 4.686

10.  Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI.

Authors:  Mary D Holdom; Anna M Davies; Joanne E Nettleship; Sarah C Bagby; Balvinder Dhaliwal; Enrico Girardi; James Hunt; Hannah J Gould; Andrew J Beavil; James M McDonnell; Ray J Owens; Brian J Sutton
Journal:  Nat Struct Mol Biol       Date:  2011-04-24       Impact factor: 15.369

View more
  65 in total

1.  Enrichment of high affinity subclasses and glycoforms from serum-derived IgG using FcγRs as affinity ligands.

Authors:  Austin W Boesch; James H Kappel; Alison E Mahan; Thach H Chu; Andrew R Crowley; Nana Y Osei-Owusu; Galit Alter; Margaret E Ackerman
Journal:  Biotechnol Bioeng       Date:  2018-02-01       Impact factor: 4.530

2.  Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis.

Authors:  Sanae Ben Mkaddem; Gilles Hayem; Friederike Jönsson; Elisabetta Rossato; Erwan Boedec; Tarek Boussetta; Jamel El Benna; Pierre Launay; Jean-Michel Goujon; Marc Benhamou; Pierre Bruhns; Renato C Monteiro
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

3.  Pentraxins and IgA share a binding hot-spot on FcαRI.

Authors:  Jinghua Lu; Kristopher D Marjon; Carolyn Mold; Lorraine Marnell; Terry W Du Clos; Peter Sun
Journal:  Protein Sci       Date:  2014-01-28       Impact factor: 6.725

4.  Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.

Authors:  Jinghua Lu; Jonathan Chu; Zhongcheng Zou; Nels B Hamacher; Mark W Rixon; Peter D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

5.  Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils.

Authors:  Agnieszka Krupa; Rafal Fudala; Jon M Florence; Torry Tucker; Timothy C Allen; Theodore J Standiford; Rafal Luchowski; Marek Fol; Moshiur Rahman; Zygmunt Gryczynski; Ignacy Gryczynski; Anna K Kurdowska
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

Review 6.  Genetics of ANCA-associated Vasculitides.

Authors:  Manuel F Ugarte-Gil; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

7.  Characterization of low affinity Fcγ receptor biotinylation under controlled reaction conditions by mass spectrometry and ligand binding analysis.

Authors:  Karin P M Geuijen; David F Egging; Stefanie Bartels; Jan Schouten; Richard B Schasfoort; Michel H Eppink
Journal:  Protein Sci       Date:  2016-08-19       Impact factor: 6.725

8.  Automated Removal of Phospholipids from Membrane Proteins for H/D Exchange Mass Spectrometry Workflows.

Authors:  Kyle W Anderson; Elyssia S Gallagher; Jeffrey W Hudgens
Journal:  Anal Chem       Date:  2018-05-09       Impact factor: 6.986

9.  Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling.

Authors:  Jing Xue; Michaele Manigrasso; Matteo Scalabrin; Vivek Rai; Sergey Reverdatto; David S Burz; Daniele Fabris; Ann Marie Schmidt; Alexander Shekhtman
Journal:  Structure       Date:  2016-08-11       Impact factor: 5.006

Review 10.  Pentraxins and Fc receptors.

Authors:  Jinghua Lu; Kristopher D Marjon; Carolyn Mold; Terry W Du Clos; Peter D Sun
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.